StockIQpro
NASDAQ:TMCI

Treace Medical Concepts, Inc.

Track all markets on TradingView
Track all markets on TradingView

Treace Medical Concepts, Inc.'s revenue grew 1.6% in fiscal 2025 to $212.7M while operating margin rose to −25.5%. Free cash flow was −$29.5M, −13.9% of revenue, and the diluted share count rose 1.9%.Summary generated from Treace Medical Concepts, Inc.'s SEC filings. Latest annual report filed Feb 27, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$212.7M
Revenue growth+1.6%
Revenue, 5-yr CAGR+30.0%
Gross margin79.8%
Operating margin−25.5%
Net margin−27.7%
ROIC−29.6%
Return on equity−58.9%
Debt / equity0.66
Free cash flow−$29.5M
FCF margin−13.9%
Share count change+1.9%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue94142187209213
Operating income−17−35−51−56−54
Net income−21−43−50−56−59
Free cash flow−20−45−46−49−29

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus